The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk HPV types (i.e., HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the main etiological agents of genital tract cancers, such as cervical, vulvar, vaginal, penile, and anal cancers, and of a...
Main Authors: | Anna Rosa Garbuglia, Daniele Lapa, Catia Sias, Maria Rosaria Capobianchi, Paola Del Porto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00188/full |
Similar Items
-
Natural history of human papillomavirus and vaccinations in men: A literature review
by: Benjamin J. Lieblong, et al.
Published: (2019-05-01) -
Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer
by: García-Carrancá Alejandro
Published: (2003-01-01) -
Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? an exploratory study
by: Hoon Choi -
HPV vaccination: the beginning of the end of cervical cancer? - A Review
by: Ana Paula Lepique, et al.
Published: (2009-02-01) -
L1tag Protein Expression of Human Papillomavirus Type 18 in Two Escherichia coli Strains, in Auto-inducing Media
by: Giovet Aldama Paz, et al.
Published: (2020-01-01)